News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Institute for International Research Release: Fortune 50 Pharmaceutical And Biotechnology Companies To Discuss Safety, Quality And Efficacy Of New And Existing Drug Products; Conference Theme: Best Practices For Good Compliance, Business And Science For Small Molecule, Proteins And Biologics


10/19/2005 5:10:45 PM

NEW YORK--(BUSINESS WIRE)--April 28, 2005--IIR September 19-21, 2005 -- Philadelphia Loews, Philadelphia PA www.bioanalyticalcongress.com On September 19-21 2005, hundreds of bioanalytical and analytical scientists, Directors and VPs of all the major pharmaceutical and biotechnology companies will meet in Philadelphia to discuss how to increase efficiencies for safety, quality and efficacy of their bioanalytical and analytical testing, methods and processes. "With declining productivity and depleting pipelines, companies are under even more pressure to slash unnecessary costs while accelerating development, all while meeting stringent compliance requirements. Companies want to test faster, cheaper and better without compromising quality." said Heej Ko, the Event Director.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES